CORTESI PAOLO ANGELO

Cortesi, P., Antonazzo, I., Palladino, P., Gnesi, M., Mele, S., D’Amelio, M., et al. (2024). Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis. ACTA DIABETOLOGICA, 61(8), 1017-1028 [10.1007/s00592-024-02276-3]. Detail

Antonazzo, I., Rozza, D., Conti, S., Fornari, C., Cortesi, P., Eteve-Pitsaer, C., et al. (2024). Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database. EUROPEAN JOURNAL OF NEUROLOGY, 31(1 (January 2024)) [10.1111/ene.16064]. Detail

Ferrari, A., Santomauro, D., Aali, A., Abate, Y., Abbafati, C., Abbastabar, H., et al. (2024). Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. THE LANCET, 403(10440), 2133-2161 [10.1016/s0140-6736(24)00757-8]. Detail

Antonazzo, I., Cortesi, P., Zanon, E., Pasca, S., Morfini, M., Santoro, C., et al. (2024). Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients. MEDICINA, 60(1) [10.3390/medicina60010034]. Detail

Steinmetz, J., Seeher, K., Schiess, N., Nichols, E., Cao, B., Servili, C., et al. (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. LANCET NEUROLOGY, 23(4), 344-381 [10.1016/S1474-4422(24)00038-3]. Detail